,i  #aafth ,,congress  #b;d ,session    
,h4 ,r4 #hebi  ,,in ,,the ,,house ,,of  
,,representatives  ,october #f1         
#bjbj,mr4 ,butterfield 7for himself1    
,mr4 ,long1 and ,mr4 ,crdenas7          
introduced the following bill2 which was
 referred to the ,committee on ,energy  
and ,commerce  ,a ,,bill  ,to amend     
title ,,xix of the ,social ,security    
,act to prohibit additional rebates     
under the ,medicaid program for certain 
noninnovator multiple source drugs4  #a4
 ,short title ,this ,act may be cited as
 the ,protecting ,access to ,affordable 
,medicines ,act of #bjbj4  #b4          
,prohibition on additional rebate under 
,medicaid for certain noninnovator      
multiple source drugs ,section          
#aibg7;c77#c77;,c7 of the ,social       
,security ,act 7#db ,u4,s4,c4           
#acifr-#h7;c77#c77;,c77 is amended--    
7#a7 in clause 7i71 by striking ,the    
amount and inserting ,subject to clause 
7v71 the amount2 and  7#b7 by adding at 
the end the following new clause3  7v7  

,prohibition on additional rebate for   
certain noninnovator multiple source    
drugs ,with respect to a rebate period  
beginning on or after ,january #a1      
#bjba1 and a dosage form and strength of
 a covered outpatient drug described in 
clause 7i71 the amount of the rebate    
specified in subparagraph 7,a7 for such 
dosage form and strength for such rebate
 period may not be increased if the     
average manufacturer price for a unit of
 such dosage form and strength for such 
rebate period is less than #a4  4